Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
No Matching Results
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Calliditas Therapeutics Ab ADR (CALT)
Calliditas Therapeutics Ab ADR (CALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing Motley Fool - Sun Mar 19, 5:24AM CDT

The high-flyers have soared to new heights and further gains could be up ahead.

TVTX : 20.88 (+2.45%)
RETA : 85.69 (-2.57%)
CALT : 22.80 (unch)
NEO : 16.87 (-7.10%)
Everest Medicines Announces Partner Calliditas Therapeutics Reports Positive Topline Results from Phase 3 NefIgArd Trial Evaluating Nefecon in IgA Nephropathy PR Newswire - Mon Mar 13, 6:30PM CDT

/PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that its partner Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq...

CALT : 22.80 (unch)
Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy PR Newswire - Sun Mar 12, 10:06PM CDT

/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced positive topline results from the global,...

CALT : 22.80 (unch)
New Strong Sell Stocks for February 27th Zacks - Mon Feb 27, 6:21AM CST

ATUS, CALT and CRC have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2023.

CRC : 37.04 (+2.69%)
ATUS : 3.09 (unch)
CALT : 22.80 (unch)
Calliditas Receives Conditional Marketing Authorization from UK MHRA for Kinpeygo in IgA nephropathy PR Newswire - Thu Feb 2, 2:44AM CST

/PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the Medicines and Healthcare products...

CALT : 22.80 (unch)
New Strong Sell Stocks for January 6th Zacks - Fri Jan 6, 6:41AM CST

CALT, CVGW and DFH have been added to the Zacks Rank #5 (Strong Sell) List on January 6, 2023.

CVGW : 26.73 (+7.52%)
CALT : 22.80 (unch)
DFH : 12.69 (+1.93%)
Calliditas CEO acquires shares through the exercise of Calliditas' warrant program 2019/2022 PR Newswire - Tue Dec 20, 2022

/PRNewswire/ -- Calliditas Therapeutics AB (publ) (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas") announced today that CEO Renée Aguiar-Lucander has net...

CALT : 22.80 (unch)
Calliditas Therapeutics announces license agreement with Viatris to register and commercialize specialty therapy for IgA nephropathy in Japan PR Newswire - Tue Dec 13, 2022

/PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") announced today that they have entered into an exclusive...

CALT : 22.80 (unch)
VTRS : 9.33 (+1.41%)
Calliditas' partner Everest Medicine's New Drug Application for Nefecon is accepted by the China NMPA PR Newswire - Tue Nov 15, 2022

/PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that the Chinese regulatory authority...

CALT : 22.80 (unch)
Aurinia (AUPH) Moves 13.1% Higher: Will This Strength Last? Zacks - Fri Oct 21, 2022

Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the...

AUPH : 10.31 (+10.98%)
CALT : 22.80 (unch)

Barchart Exclusives

2 Stocks to Buy With Unusual Options Activity Other Than Tesla Barchart - Fri Mar 24, 12:00PM CDT
Six out of Thursday’s top 10 options based on volume exhibiting unusual options activity were Tesla. That’s not surprising. What was is that TSLA had zero in the top 25 when it comes to the Vol/OI ratio. These two stocks did. They’re potential long-term buys.   Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot